nodes	percent_of_prediction	percent_of_DWPC	metapath
Spironolactone—PGR—ovarian cancer	0.378	0.788	CbGaD
Spironolactone—SLCO1A2—Chlorambucil—ovarian cancer	0.127	0.388	CbGbCtD
Spironolactone—ABCB1—ovarian cancer	0.101	0.211	CbGaD
Spironolactone—ABCC2—Paclitaxel—ovarian cancer	0.0362	0.11	CbGbCtD
Spironolactone—ABCC2—Carboplatin—ovarian cancer	0.0341	0.104	CbGbCtD
Spironolactone—ABCC2—Docetaxel—ovarian cancer	0.0262	0.0798	CbGbCtD
Spironolactone—ABCB1—Topotecan—ovarian cancer	0.0239	0.0727	CbGbCtD
Spironolactone—ABCC2—Doxorubicin—ovarian cancer	0.0195	0.0595	CbGbCtD
Spironolactone—CYP2C8—Paclitaxel—ovarian cancer	0.0174	0.0532	CbGbCtD
Spironolactone—ABCB1—Vinorelbine—ovarian cancer	0.0168	0.0512	CbGbCtD
Spironolactone—ABCB1—Paclitaxel—ovarian cancer	0.0118	0.036	CbGbCtD
Spironolactone—PGR—corpus luteum—ovarian cancer	0.00971	0.156	CbGeAlD
Spironolactone—ABCB1—Docetaxel—ovarian cancer	0.00854	0.026	CbGbCtD
Spironolactone—PGR—ovarian follicle—ovarian cancer	0.00759	0.122	CbGeAlD
Spironolactone—ABCB1—Doxorubicin—ovarian cancer	0.00636	0.0194	CbGbCtD
Spironolactone—PGR—oviduct—ovarian cancer	0.00334	0.0535	CbGeAlD
Spironolactone—Carcinoma breast—Docetaxel—ovarian cancer	0.00332	0.0461	CcSEcCtD
Spironolactone—Drug fever—Chlorambucil—ovarian cancer	0.0031	0.043	CcSEcCtD
Spironolactone—AR—oviduct—ovarian cancer	0.00266	0.0426	CbGeAlD
Spironolactone—Ataxia—Altretamine—ovarian cancer	0.00199	0.0276	CcSEcCtD
Spironolactone—Drug fever—Docetaxel—ovarian cancer	0.00135	0.0187	CcSEcCtD
Spironolactone—Breast cancer—Docetaxel—ovarian cancer	0.00123	0.0171	CcSEcCtD
Spironolactone—Rash erythematous—Topotecan—ovarian cancer	0.0012	0.0167	CcSEcCtD
Spironolactone—Amenorrhoea—Chlorambucil—ovarian cancer	0.00118	0.0163	CcSEcCtD
Spironolactone—NR3C2—myometrium—ovarian cancer	0.00115	0.0184	CbGeAlD
Spironolactone—Leukopenia—Altretamine—ovarian cancer	0.00114	0.0158	CcSEcCtD
Spironolactone—PGR—myometrium—ovarian cancer	0.00107	0.0171	CbGeAlD
Spironolactone—Amenorrhoea—Melphalan—ovarian cancer	0.00103	0.0142	CcSEcCtD
Spironolactone—Thrombocytopenia—Altretamine—ovarian cancer	0.00102	0.0141	CcSEcCtD
Spironolactone—Dydrogesterone—PGR—ovarian cancer	0.000989	0.251	CrCbGaD
Spironolactone—Ulcer—Melphalan—ovarian cancer	0.000953	0.0132	CcSEcCtD
Spironolactone—Vasculitis—Melphalan—ovarian cancer	0.000924	0.0128	CcSEcCtD
Spironolactone—NR3C2—uterine cervix—ovarian cancer	0.000893	0.0143	CbGeAlD
Spironolactone—CYP11B2—lymph node—ovarian cancer	0.000887	0.0142	CbGeAlD
Spironolactone—AR—myometrium—ovarian cancer	0.00085	0.0136	CbGeAlD
Spironolactone—PGR—epithelium—ovarian cancer	0.000838	0.0134	CbGeAlD
Spironolactone—SHBG—endometrium—ovarian cancer	0.000834	0.0134	CbGeAlD
Spironolactone—PGR—uterine cervix—ovarian cancer	0.000831	0.0133	CbGeAlD
Spironolactone—Renal failure acute—Chlorambucil—ovarian cancer	0.000813	0.0113	CcSEcCtD
Spironolactone—Menstruation irregular—Docetaxel—ovarian cancer	0.000811	0.0113	CcSEcCtD
Spironolactone—NR3C2—endometrium—ovarian cancer	0.000808	0.013	CbGeAlD
Spironolactone—PGR—decidua—ovarian cancer	0.000791	0.0127	CbGeAlD
Spironolactone—SHBG—gonad—ovarian cancer	0.000773	0.0124	CbGeAlD
Spironolactone—SHBG—uterus—ovarian cancer	0.000768	0.0123	CbGeAlD
Spironolactone—PGR—endometrium—ovarian cancer	0.000751	0.012	CbGeAlD
Spironolactone—NR3C2—uterus—ovarian cancer	0.000745	0.0119	CbGeAlD
Spironolactone—Renal failure acute—Melphalan—ovarian cancer	0.000709	0.00984	CcSEcCtD
Spironolactone—Ataxia—Chlorambucil—ovarian cancer	0.000706	0.0098	CcSEcCtD
Spironolactone—PGR—uterus—ovarian cancer	0.000692	0.0111	CbGeAlD
Spironolactone—Rash erythematous—Paclitaxel—ovarian cancer	0.000692	0.0096	CcSEcCtD
Spironolactone—SHBG—female reproductive system—ovarian cancer	0.000691	0.0111	CbGeAlD
Spironolactone—Dizziness—Altretamine—ovarian cancer	0.000687	0.00953	CcSEcCtD
Spironolactone—Lethargy—Topotecan—ovarian cancer	0.000682	0.00947	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Chlorambucil—ovarian cancer	0.000676	0.00939	CcSEcCtD
Spironolactone—NR3C2—female reproductive system—ovarian cancer	0.000669	0.0107	CbGeAlD
Spironolactone—AR—epithelium—ovarian cancer	0.000667	0.0107	CbGeAlD
Spironolactone—AR—uterine cervix—ovarian cancer	0.000662	0.0106	CbGeAlD
Spironolactone—Vomiting—Altretamine—ovarian cancer	0.00066	0.00917	CcSEcCtD
Spironolactone—SHBG—bone marrow—ovarian cancer	0.000652	0.0105	CbGeAlD
Spironolactone—AR—decidua—ovarian cancer	0.00063	0.0101	CbGeAlD
Spironolactone—SHBG—female gonad—ovarian cancer	0.000629	0.0101	CbGeAlD
Spironolactone—SHBG—vagina—ovarian cancer	0.000625	0.01	CbGeAlD
Spironolactone—PGR—female reproductive system—ovarian cancer	0.000622	0.00997	CbGeAlD
Spironolactone—Nausea—Altretamine—ovarian cancer	0.000617	0.00856	CcSEcCtD
Spironolactone—NR3C1—myometrium—ovarian cancer	0.000616	0.00987	CbGeAlD
Spironolactone—NR3C2—female gonad—ovarian cancer	0.000609	0.00976	CbGeAlD
Spironolactone—Breast pain—Paclitaxel—ovarian cancer	0.000607	0.00843	CcSEcCtD
Spironolactone—NR3C2—vagina—ovarian cancer	0.000605	0.0097	CbGeAlD
Spironolactone—Cramp muscle—Topotecan—ovarian cancer	0.000602	0.00836	CcSEcCtD
Spironolactone—AR—endometrium—ovarian cancer	0.000598	0.00959	CbGeAlD
Spironolactone—Megestrol acetate—PGR—ovarian cancer	0.000595	0.151	CrCbGaD
Spironolactone—NR3C1—embryo—ovarian cancer	0.000592	0.00949	CbGeAlD
Spironolactone—Rash erythematous—Docetaxel—ovarian cancer	0.000586	0.00814	CcSEcCtD
Spironolactone—Lethargy—Vinorelbine—ovarian cancer	0.000583	0.0081	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Chlorambucil—ovarian cancer	0.000574	0.00796	CcSEcCtD
Spironolactone—Body temperature increased—Carboplatin—ovarian cancer	0.000567	0.00787	CcSEcCtD
Spironolactone—PGR—female gonad—ovarian cancer	0.000566	0.00908	CbGeAlD
Spironolactone—PGR—vagina—ovarian cancer	0.000563	0.00902	CbGeAlD
Spironolactone—SHBG—testis—ovarian cancer	0.000558	0.00894	CbGeAlD
Spironolactone—AR—gonad—ovarian cancer	0.000555	0.0089	CbGeAlD
Spironolactone—AR—uterus—ovarian cancer	0.000552	0.00884	CbGeAlD
Spironolactone—NR3C2—testis—ovarian cancer	0.00054	0.00866	CbGeAlD
Spironolactone—ABCC2—female reproductive system—ovarian cancer	0.000535	0.00857	CbGeAlD
Spironolactone—Drospirenone—PGR—ovarian cancer	0.000519	0.132	CrCbGaD
Spironolactone—Amenorrhoea—Docetaxel—ovarian cancer	0.000511	0.0071	CcSEcCtD
Spironolactone—PGR—testis—ovarian cancer	0.000502	0.00805	CbGeAlD
Spironolactone—AR—female reproductive system—ovarian cancer	0.000496	0.00795	CbGeAlD
Spironolactone—Erythema multiforme—Chlorambucil—ovarian cancer	0.000491	0.00682	CcSEcCtD
Spironolactone—Cramps of lower extremities—Paclitaxel—ovarian cancer	0.000487	0.00676	CcSEcCtD
Spironolactone—CYP2C8—endometrium—ovarian cancer	0.000484	0.00776	CbGeAlD
Spironolactone—NR3C1—epithelium—ovarian cancer	0.000483	0.00775	CbGeAlD
Spironolactone—NR3C1—uterine cervix—ovarian cancer	0.000479	0.00768	CbGeAlD
Spironolactone—SLCO1A2—testis—ovarian cancer	0.000463	0.00742	CbGeAlD
Spironolactone—Alopecia—Chlorambucil—ovarian cancer	0.000459	0.00637	CcSEcCtD
Spironolactone—NR3C1—decidua—ovarian cancer	0.000457	0.00732	CbGeAlD
Spironolactone—AR—female gonad—ovarian cancer	0.000451	0.00723	CbGeAlD
Spironolactone—AR—vagina—ovarian cancer	0.000448	0.00719	CbGeAlD
Spironolactone—NR3C1—endometrium—ovarian cancer	0.000433	0.00695	CbGeAlD
Spironolactone—ABCC2—testis—ovarian cancer	0.000431	0.00691	CbGeAlD
Spironolactone—Renal failure acute—Paclitaxel—ovarian cancer	0.000417	0.00578	CcSEcCtD
Spironolactone—Agranulocytosis—Vinorelbine—ovarian cancer	0.000411	0.00571	CcSEcCtD
Spironolactone—Alopecia—Topotecan—ovarian cancer	0.000409	0.00567	CcSEcCtD
Spironolactone—Leukopenia—Chlorambucil—ovarian cancer	0.000405	0.00562	CcSEcCtD
Spironolactone—NR3C1—gonad—ovarian cancer	0.000402	0.00644	CbGeAlD
Spironolactone—CYP2C8—female reproductive system—ovarian cancer	0.000401	0.00643	CbGeAlD
Spironolactone—AR—testis—ovarian cancer	0.0004	0.00641	CbGeAlD
Spironolactone—Alopecia—Melphalan—ovarian cancer	0.0004	0.00555	CcSEcCtD
Spironolactone—NR3C1—uterus—ovarian cancer	0.000399	0.0064	CbGeAlD
Spironolactone—Rash erythematous—Epirubicin—ovarian cancer	0.000395	0.00549	CcSEcCtD
Spironolactone—Lethargy—Paclitaxel—ovarian cancer	0.000392	0.00545	CcSEcCtD
Spironolactone—NR3C2—lymph node—ovarian cancer	0.000392	0.00628	CbGeAlD
Spironolactone—Muscle spasms—Topotecan—ovarian cancer	0.000387	0.00537	CcSEcCtD
Spironolactone—Ill-defined disorder—Topotecan—ovarian cancer	0.000373	0.00518	CcSEcCtD
Spironolactone—Confusional state—Chlorambucil—ovarian cancer	0.000372	0.00517	CcSEcCtD
Spironolactone—Rash erythematous—Doxorubicin—ovarian cancer	0.000366	0.00508	CcSEcCtD
Spironolactone—PGR—lymph node—ovarian cancer	0.000364	0.00583	CbGeAlD
Spironolactone—Malaise—Topotecan—ovarian cancer	0.000363	0.00504	CcSEcCtD
Spironolactone—CYP2C8—vagina—ovarian cancer	0.000363	0.00581	CbGeAlD
Spironolactone—Ataxia—Paclitaxel—ovarian cancer	0.000362	0.00502	CcSEcCtD
Spironolactone—Thrombocytopenia—Chlorambucil—ovarian cancer	0.000361	0.00502	CcSEcCtD
Spironolactone—Leukopenia—Topotecan—ovarian cancer	0.00036	0.005	CcSEcCtD
Spironolactone—NR3C1—female reproductive system—ovarian cancer	0.000359	0.00576	CbGeAlD
Spironolactone—Leukopenia—Melphalan—ovarian cancer	0.000353	0.0049	CcSEcCtD
Spironolactone—Alopecia—Vinorelbine—ovarian cancer	0.000349	0.00485	CcSEcCtD
Spironolactone—Breast pain—Epirubicin—ovarian cancer	0.000347	0.00482	CcSEcCtD
Spironolactone—Medroxyprogesterone Acetate—PGR—ovarian cancer	0.000347	0.0879	CrCbGaD
Spironolactone—Cramp muscle—Paclitaxel—ovarian cancer	0.000346	0.00481	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Paclitaxel—ovarian cancer	0.000346	0.00481	CcSEcCtD
Spironolactone—Amenorrhoea—Epirubicin—ovarian cancer	0.000345	0.00479	CcSEcCtD
Spironolactone—NR3C1—bone marrow—ovarian cancer	0.000339	0.00543	CbGeAlD
Spironolactone—Discomfort—Topotecan—ovarian cancer	0.000339	0.0047	CcSEcCtD
Spironolactone—Lethargy—Docetaxel—ovarian cancer	0.000333	0.00462	CcSEcCtD
Spironolactone—ABCB1—myometrium—ovarian cancer	0.00033	0.00528	CbGeAlD
Spironolactone—Anaphylactic shock—Topotecan—ovarian cancer	0.000328	0.00456	CcSEcCtD
Spironolactone—NR3C1—female gonad—ovarian cancer	0.000327	0.00524	CbGeAlD
Spironolactone—NR3C1—vagina—ovarian cancer	0.000325	0.00521	CbGeAlD
Spironolactone—CYP2C8—testis—ovarian cancer	0.000324	0.00519	CbGeAlD
Spironolactone—Anaphylactic shock—Melphalan—ovarian cancer	0.000322	0.00447	CcSEcCtD
Spironolactone—Thrombocytopenia—Topotecan—ovarian cancer	0.000322	0.00447	CcSEcCtD
Spironolactone—Breast pain—Doxorubicin—ovarian cancer	0.000321	0.00446	CcSEcCtD
Spironolactone—Ulcer—Epirubicin—ovarian cancer	0.00032	0.00445	CcSEcCtD
Spironolactone—Ill-defined disorder—Vinorelbine—ovarian cancer	0.000319	0.00444	CcSEcCtD
Spironolactone—Amenorrhoea—Doxorubicin—ovarian cancer	0.000319	0.00443	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Chlorambucil—ovarian cancer	0.000319	0.00442	CcSEcCtD
Spironolactone—ABCB1—embryo—ovarian cancer	0.000317	0.00508	CbGeAlD
Spironolactone—Thrombocytopenia—Melphalan—ovarian cancer	0.000315	0.00437	CcSEcCtD
Spironolactone—ABCC2—lymph node—ovarian cancer	0.000313	0.00501	CbGeAlD
Spironolactone—Malaise—Vinorelbine—ovarian cancer	0.00031	0.00431	CcSEcCtD
Spironolactone—Leukopenia—Vinorelbine—ovarian cancer	0.000308	0.00428	CcSEcCtD
Spironolactone—Ataxia—Docetaxel—ovarian cancer	0.000306	0.00426	CcSEcCtD
Spironolactone—Feeling abnormal—Chlorambucil—ovarian cancer	0.000304	0.00422	CcSEcCtD
Spironolactone—Hyperkalaemia—Epirubicin—ovarian cancer	0.000298	0.00413	CcSEcCtD
Spironolactone—Ulcer—Doxorubicin—ovarian cancer	0.000296	0.00411	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Paclitaxel—ovarian cancer	0.000294	0.00408	CcSEcCtD
Spironolactone—Cramp muscle—Docetaxel—ovarian cancer	0.000294	0.00408	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Docetaxel—ovarian cancer	0.000294	0.00408	CcSEcCtD
Spironolactone—Urticaria—Chlorambucil—ovarian cancer	0.000293	0.00407	CcSEcCtD
Spironolactone—Body temperature increased—Chlorambucil—ovarian cancer	0.000292	0.00405	CcSEcCtD
Spironolactone—Renal failure—Paclitaxel—ovarian cancer	0.000291	0.00404	CcSEcCtD
Spironolactone—AR—lymph node—ovarian cancer	0.00029	0.00465	CbGeAlD
Spironolactone—NR3C1—testis—ovarian cancer	0.00029	0.00464	CbGeAlD
Spironolactone—Discomfort—Vinorelbine—ovarian cancer	0.00029	0.00402	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Topotecan—ovarian cancer	0.000284	0.00394	CcSEcCtD
Spironolactone—Anaphylactic shock—Vinorelbine—ovarian cancer	0.000281	0.0039	CcSEcCtD
Spironolactone—Cramps of lower extremities—Epirubicin—ovarian cancer	0.000278	0.00386	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Melphalan—ovarian cancer	0.000278	0.00386	CcSEcCtD
Spironolactone—Hyperkalaemia—Doxorubicin—ovarian cancer	0.000275	0.00382	CcSEcCtD
Spironolactone—Thrombocytopenia—Vinorelbine—ovarian cancer	0.000275	0.00382	CcSEcCtD
Spironolactone—Hypersensitivity—Chlorambucil—ovarian cancer	0.000272	0.00377	CcSEcCtD
Spironolactone—Feeling abnormal—Topotecan—ovarian cancer	0.000271	0.00376	CcSEcCtD
Spironolactone—Pruritus—Chlorambucil—ovarian cancer	0.000261	0.00362	CcSEcCtD
Spironolactone—Urticaria—Topotecan—ovarian cancer	0.000261	0.00362	CcSEcCtD
Spironolactone—Body temperature increased—Topotecan—ovarian cancer	0.00026	0.00361	CcSEcCtD
Spironolactone—ABCB1—epithelium—ovarian cancer	0.000259	0.00415	CbGeAlD
Spironolactone—Cramps of lower extremities—Doxorubicin—ovarian cancer	0.000257	0.00357	CcSEcCtD
Spironolactone—ABCB1—uterine cervix—ovarian cancer	0.000257	0.00411	CbGeAlD
Spironolactone—Urticaria—Melphalan—ovarian cancer	0.000256	0.00355	CcSEcCtD
Spironolactone—Fluoxymesterone—ESR1—ovarian cancer	0.000255	0.0647	CrCbGaD
Spironolactone—Diarrhoea—Chlorambucil—ovarian cancer	0.000252	0.00351	CcSEcCtD
Spironolactone—Erythema multiforme—Paclitaxel—ovarian cancer	0.000252	0.00349	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Docetaxel—ovarian cancer	0.000249	0.00346	CcSEcCtD
Spironolactone—Renal failure—Docetaxel—ovarian cancer	0.000247	0.00343	CcSEcCtD
Spironolactone—ABCB1—decidua—ovarian cancer	0.000244	0.00392	CbGeAlD
Spironolactone—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.000243	0.00337	CcSEcCtD
Spironolactone—Hypersensitivity—Topotecan—ovarian cancer	0.000242	0.00336	CcSEcCtD
Spironolactone—Renal failure acute—Epirubicin—ovarian cancer	0.000238	0.00331	CcSEcCtD
Spironolactone—Hypersensitivity—Melphalan—ovarian cancer	0.000237	0.00329	CcSEcCtD
Spironolactone—Alopecia—Paclitaxel—ovarian cancer	0.000235	0.00326	CcSEcCtD
Spironolactone—Vomiting—Chlorambucil—ovarian cancer	0.000235	0.00326	CcSEcCtD
Spironolactone—Agranulocytosis—Docetaxel—ovarian cancer	0.000234	0.00325	CcSEcCtD
Spironolactone—Pruritus—Topotecan—ovarian cancer	0.000232	0.00323	CcSEcCtD
Spironolactone—ABCB1—endometrium—ovarian cancer	0.000232	0.00372	CbGeAlD
Spironolactone—Feeling abnormal—Vinorelbine—ovarian cancer	0.000232	0.00322	CcSEcCtD
Spironolactone—Pruritus—Melphalan—ovarian cancer	0.000228	0.00316	CcSEcCtD
Spironolactone—Diarrhoea—Topotecan—ovarian cancer	0.000225	0.00312	CcSEcCtD
Spironolactone—Lethargy—Epirubicin—ovarian cancer	0.000224	0.00311	CcSEcCtD
Spironolactone—Urticaria—Vinorelbine—ovarian cancer	0.000223	0.0031	CcSEcCtD
Spironolactone—Muscle spasms—Paclitaxel—ovarian cancer	0.000223	0.00309	CcSEcCtD
Spironolactone—Body temperature increased—Vinorelbine—ovarian cancer	0.000222	0.00308	CcSEcCtD
Spironolactone—Renal failure acute—Doxorubicin—ovarian cancer	0.00022	0.00306	CcSEcCtD
Spironolactone—Diarrhoea—Melphalan—ovarian cancer	0.00022	0.00306	CcSEcCtD
Spironolactone—Nausea—Chlorambucil—ovarian cancer	0.000219	0.00304	CcSEcCtD
Spironolactone—Medroxyprogesterone Acetate—ESR1—ovarian cancer	0.000219	0.0555	CrCbGaD
Spironolactone—Dizziness—Topotecan—ovarian cancer	0.000217	0.00302	CcSEcCtD
Spironolactone—ABCB1—gonad—ovarian cancer	0.000215	0.00345	CbGeAlD
Spironolactone—Ill-defined disorder—Paclitaxel—ovarian cancer	0.000215	0.00298	CcSEcCtD
Spironolactone—ABCB1—uterus—ovarian cancer	0.000214	0.00343	CbGeAlD
Spironolactone—Erythema multiforme—Docetaxel—ovarian cancer	0.000213	0.00296	CcSEcCtD
Spironolactone—NR3C1—lymph node—ovarian cancer	0.00021	0.00337	CbGeAlD
Spironolactone—Vomiting—Topotecan—ovarian cancer	0.000209	0.0029	CcSEcCtD
Spironolactone—Malaise—Paclitaxel—ovarian cancer	0.000209	0.0029	CcSEcCtD
Spironolactone—Lethargy—Doxorubicin—ovarian cancer	0.000208	0.00288	CcSEcCtD
Spironolactone—Leukopenia—Paclitaxel—ovarian cancer	0.000207	0.00288	CcSEcCtD
Spironolactone—Rash—Topotecan—ovarian cancer	0.000207	0.00288	CcSEcCtD
Spironolactone—Hypersensitivity—Vinorelbine—ovarian cancer	0.000207	0.00287	CcSEcCtD
Spironolactone—Dermatitis—Topotecan—ovarian cancer	0.000207	0.00287	CcSEcCtD
Spironolactone—Ataxia—Epirubicin—ovarian cancer	0.000207	0.00287	CcSEcCtD
Spironolactone—Headache—Topotecan—ovarian cancer	0.000206	0.00286	CcSEcCtD
Spironolactone—Vomiting—Melphalan—ovarian cancer	0.000204	0.00284	CcSEcCtD
Spironolactone—Rash—Melphalan—ovarian cancer	0.000203	0.00282	CcSEcCtD
Spironolactone—Dermatitis—Melphalan—ovarian cancer	0.000203	0.00281	CcSEcCtD
Spironolactone—Progesterone—PGR—ovarian cancer	0.0002	0.0507	CrCbGaD
Spironolactone—Alopecia—Docetaxel—ovarian cancer	0.000199	0.00277	CcSEcCtD
Spironolactone—Pruritus—Vinorelbine—ovarian cancer	0.000199	0.00276	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Epirubicin—ovarian cancer	0.000198	0.00275	CcSEcCtD
Spironolactone—Nausea—Topotecan—ovarian cancer	0.000195	0.00271	CcSEcCtD
Spironolactone—Discomfort—Paclitaxel—ovarian cancer	0.000195	0.0027	CcSEcCtD
Spironolactone—Gastritis—Epirubicin—ovarian cancer	0.000195	0.0027	CcSEcCtD
Spironolactone—Diarrhoea—Vinorelbine—ovarian cancer	0.000192	0.00267	CcSEcCtD
Spironolactone—ABCB1—female reproductive system—ovarian cancer	0.000192	0.00308	CbGeAlD
Spironolactone—Ataxia—Doxorubicin—ovarian cancer	0.000191	0.00266	CcSEcCtD
Spironolactone—Nausea—Melphalan—ovarian cancer	0.000191	0.00265	CcSEcCtD
Spironolactone—Confusional state—Paclitaxel—ovarian cancer	0.000191	0.00265	CcSEcCtD
Spironolactone—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000189	0.00262	CcSEcCtD
Spironolactone—Muscle spasms—Docetaxel—ovarian cancer	0.000189	0.00262	CcSEcCtD
Spironolactone—Eosinophilia—Epirubicin—ovarian cancer	0.000188	0.00261	CcSEcCtD
Spironolactone—Progesterone—CYP1B1—ovarian cancer	0.000187	0.0474	CrCbGaD
Spironolactone—Dizziness—Vinorelbine—ovarian cancer	0.000186	0.00258	CcSEcCtD
Spironolactone—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000185	0.00257	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.000183	0.00254	CcSEcCtD
Spironolactone—ABCB1—bone marrow—ovarian cancer	0.000181	0.00291	CbGeAlD
Spironolactone—Gastritis—Doxorubicin—ovarian cancer	0.00018	0.0025	CcSEcCtD
Spironolactone—Vomiting—Vinorelbine—ovarian cancer	0.000179	0.00248	CcSEcCtD
Spironolactone—Rash—Vinorelbine—ovarian cancer	0.000177	0.00246	CcSEcCtD
Spironolactone—Dermatitis—Vinorelbine—ovarian cancer	0.000177	0.00246	CcSEcCtD
Spironolactone—Testosterone—CYP1B1—ovarian cancer	0.000177	0.0448	CrCbGaD
Spironolactone—Headache—Vinorelbine—ovarian cancer	0.000176	0.00244	CcSEcCtD
Spironolactone—Leukopenia—Docetaxel—ovarian cancer	0.000176	0.00244	CcSEcCtD
Spironolactone—ABCB1—female gonad—ovarian cancer	0.000175	0.0028	CbGeAlD
Spironolactone—Eosinophilia—Doxorubicin—ovarian cancer	0.000174	0.00242	CcSEcCtD
Spironolactone—ABCB1—vagina—ovarian cancer	0.000174	0.00279	CbGeAlD
Spironolactone—Drowsiness—Epirubicin—ovarian cancer	0.000169	0.00235	CcSEcCtD
Spironolactone—Somnolence—Paclitaxel—ovarian cancer	0.000168	0.00233	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.000168	0.00233	CcSEcCtD
Spironolactone—Nausea—Vinorelbine—ovarian cancer	0.000167	0.00232	CcSEcCtD
Spironolactone—Renal failure—Epirubicin—ovarian cancer	0.000167	0.00231	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000163	0.00227	CcSEcCtD
Spironolactone—Confusional state—Docetaxel—ovarian cancer	0.000162	0.00224	CcSEcCtD
Spironolactone—Anaphylactic shock—Docetaxel—ovarian cancer	0.00016	0.00222	CcSEcCtD
Spironolactone—Megestrol acetate—ABCB1—ovarian cancer	0.00016	0.0405	CrCbGaD
Spironolactone—Agranulocytosis—Epirubicin—ovarian cancer	0.000158	0.0022	CcSEcCtD
Spironolactone—Thrombocytopenia—Docetaxel—ovarian cancer	0.000157	0.00218	CcSEcCtD
Spironolactone—Drowsiness—Doxorubicin—ovarian cancer	0.000157	0.00218	CcSEcCtD
Spironolactone—Feeling abnormal—Paclitaxel—ovarian cancer	0.000156	0.00216	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000155	0.00216	CcSEcCtD
Spironolactone—ABCB1—testis—ovarian cancer	0.000155	0.00249	CbGeAlD
Spironolactone—Renal failure—Doxorubicin—ovarian cancer	0.000154	0.00214	CcSEcCtD
Spironolactone—Urticaria—Paclitaxel—ovarian cancer	0.00015	0.00208	CcSEcCtD
Spironolactone—Body temperature increased—Paclitaxel—ovarian cancer	0.000149	0.00207	CcSEcCtD
Spironolactone—Agranulocytosis—Doxorubicin—ovarian cancer	0.000146	0.00203	CcSEcCtD
Spironolactone—Erythema multiforme—Epirubicin—ovarian cancer	0.000144	0.002	CcSEcCtD
Spironolactone—Somnolence—Docetaxel—ovarian cancer	0.000142	0.00198	CcSEcCtD
Spironolactone—Hypersensitivity—Paclitaxel—ovarian cancer	0.000139	0.00193	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000138	0.00192	CcSEcCtD
Spironolactone—Alopecia—Epirubicin—ovarian cancer	0.000134	0.00187	CcSEcCtD
Spironolactone—Pruritus—Paclitaxel—ovarian cancer	0.000134	0.00186	CcSEcCtD
Spironolactone—Erythema multiforme—Doxorubicin—ovarian cancer	0.000133	0.00185	CcSEcCtD
Spironolactone—Feeling abnormal—Docetaxel—ovarian cancer	0.000132	0.00183	CcSEcCtD
Spironolactone—Diarrhoea—Paclitaxel—ovarian cancer	0.000129	0.0018	CcSEcCtD
Spironolactone—Muscle spasms—Epirubicin—ovarian cancer	0.000127	0.00177	CcSEcCtD
Spironolactone—Body temperature increased—Docetaxel—ovarian cancer	0.000127	0.00176	CcSEcCtD
Spironolactone—Progesterone—ESR1—ovarian cancer	0.000126	0.032	CrCbGaD
Spironolactone—Dizziness—Paclitaxel—ovarian cancer	0.000125	0.00174	CcSEcCtD
Spironolactone—Alopecia—Doxorubicin—ovarian cancer	0.000124	0.00173	CcSEcCtD
Spironolactone—Ill-defined disorder—Epirubicin—ovarian cancer	0.000123	0.00171	CcSEcCtD
Spironolactone—Vomiting—Paclitaxel—ovarian cancer	0.00012	0.00167	CcSEcCtD
Spironolactone—Malaise—Epirubicin—ovarian cancer	0.000119	0.00166	CcSEcCtD
Spironolactone—Rash—Paclitaxel—ovarian cancer	0.000119	0.00165	CcSEcCtD
Spironolactone—Dermatitis—Paclitaxel—ovarian cancer	0.000119	0.00165	CcSEcCtD
Spironolactone—Leukopenia—Epirubicin—ovarian cancer	0.000119	0.00165	CcSEcCtD
Spironolactone—Headache—Paclitaxel—ovarian cancer	0.000118	0.00164	CcSEcCtD
Spironolactone—Hypersensitivity—Docetaxel—ovarian cancer	0.000118	0.00164	CcSEcCtD
Spironolactone—Muscle spasms—Doxorubicin—ovarian cancer	0.000118	0.00164	CcSEcCtD
Spironolactone—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000114	0.00158	CcSEcCtD
Spironolactone—Pruritus—Docetaxel—ovarian cancer	0.000113	0.00157	CcSEcCtD
Spironolactone—ABCB1—lymph node—ovarian cancer	0.000112	0.0018	CbGeAlD
Spironolactone—Nausea—Paclitaxel—ovarian cancer	0.000112	0.00156	CcSEcCtD
Spironolactone—Discomfort—Epirubicin—ovarian cancer	0.000111	0.00155	CcSEcCtD
Spironolactone—Malaise—Doxorubicin—ovarian cancer	0.00011	0.00153	CcSEcCtD
Spironolactone—Leukopenia—Doxorubicin—ovarian cancer	0.00011	0.00152	CcSEcCtD
Spironolactone—Diarrhoea—Docetaxel—ovarian cancer	0.00011	0.00152	CcSEcCtD
Spironolactone—Confusional state—Epirubicin—ovarian cancer	0.000109	0.00151	CcSEcCtD
Spironolactone—Anaphylactic shock—Epirubicin—ovarian cancer	0.000108	0.0015	CcSEcCtD
Spironolactone—Dizziness—Docetaxel—ovarian cancer	0.000106	0.00147	CcSEcCtD
Spironolactone—Thrombocytopenia—Epirubicin—ovarian cancer	0.000106	0.00147	CcSEcCtD
Spironolactone—Discomfort—Doxorubicin—ovarian cancer	0.000103	0.00143	CcSEcCtD
Spironolactone—Vomiting—Docetaxel—ovarian cancer	0.000102	0.00141	CcSEcCtD
Spironolactone—Rash—Docetaxel—ovarian cancer	0.000101	0.0014	CcSEcCtD
Spironolactone—Dermatitis—Docetaxel—ovarian cancer	0.000101	0.0014	CcSEcCtD
Spironolactone—Confusional state—Doxorubicin—ovarian cancer	0.000101	0.0014	CcSEcCtD
Spironolactone—Headache—Docetaxel—ovarian cancer	0.0001	0.00139	CcSEcCtD
Spironolactone—Anaphylactic shock—Doxorubicin—ovarian cancer	0.0001	0.00139	CcSEcCtD
Spironolactone—Thrombocytopenia—Doxorubicin—ovarian cancer	9.79e-05	0.00136	CcSEcCtD
Spironolactone—Somnolence—Epirubicin—ovarian cancer	9.61e-05	0.00133	CcSEcCtD
Spironolactone—Nausea—Docetaxel—ovarian cancer	9.52e-05	0.00132	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Epirubicin—ovarian cancer	9.33e-05	0.0013	CcSEcCtD
Spironolactone—Feeling abnormal—Epirubicin—ovarian cancer	8.9e-05	0.00124	CcSEcCtD
Spironolactone—Somnolence—Doxorubicin—ovarian cancer	8.89e-05	0.00123	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Doxorubicin—ovarian cancer	8.63e-05	0.0012	CcSEcCtD
Spironolactone—Urticaria—Epirubicin—ovarian cancer	8.58e-05	0.00119	CcSEcCtD
Spironolactone—Body temperature increased—Epirubicin—ovarian cancer	8.54e-05	0.00119	CcSEcCtD
Spironolactone—Feeling abnormal—Doxorubicin—ovarian cancer	8.24e-05	0.00114	CcSEcCtD
Spironolactone—Hypersensitivity—Epirubicin—ovarian cancer	7.96e-05	0.00111	CcSEcCtD
Spironolactone—Urticaria—Doxorubicin—ovarian cancer	7.94e-05	0.0011	CcSEcCtD
Spironolactone—Body temperature increased—Doxorubicin—ovarian cancer	7.9e-05	0.0011	CcSEcCtD
Spironolactone—Pruritus—Epirubicin—ovarian cancer	7.64e-05	0.00106	CcSEcCtD
Spironolactone—Diarrhoea—Epirubicin—ovarian cancer	7.39e-05	0.00103	CcSEcCtD
Spironolactone—Hypersensitivity—Doxorubicin—ovarian cancer	7.37e-05	0.00102	CcSEcCtD
Spironolactone—Dizziness—Epirubicin—ovarian cancer	7.15e-05	0.000992	CcSEcCtD
Spironolactone—Pruritus—Doxorubicin—ovarian cancer	7.07e-05	0.000982	CcSEcCtD
Spironolactone—Vomiting—Epirubicin—ovarian cancer	6.87e-05	0.000954	CcSEcCtD
Spironolactone—Diarrhoea—Doxorubicin—ovarian cancer	6.84e-05	0.00095	CcSEcCtD
Spironolactone—Rash—Epirubicin—ovarian cancer	6.81e-05	0.000946	CcSEcCtD
Spironolactone—Dermatitis—Epirubicin—ovarian cancer	6.81e-05	0.000945	CcSEcCtD
Spironolactone—Headache—Epirubicin—ovarian cancer	6.77e-05	0.00094	CcSEcCtD
Spironolactone—Dizziness—Doxorubicin—ovarian cancer	6.61e-05	0.000918	CcSEcCtD
Spironolactone—Hydrocortisone—ABCB1—ovarian cancer	6.59e-05	0.0167	CrCbGaD
Spironolactone—Nausea—Epirubicin—ovarian cancer	6.42e-05	0.000891	CcSEcCtD
Spironolactone—Vomiting—Doxorubicin—ovarian cancer	6.36e-05	0.000883	CcSEcCtD
Spironolactone—Rash—Doxorubicin—ovarian cancer	6.3e-05	0.000875	CcSEcCtD
Spironolactone—Dermatitis—Doxorubicin—ovarian cancer	6.3e-05	0.000874	CcSEcCtD
Spironolactone—Headache—Doxorubicin—ovarian cancer	6.26e-05	0.00087	CcSEcCtD
Spironolactone—Nausea—Doxorubicin—ovarian cancer	5.94e-05	0.000825	CcSEcCtD
Spironolactone—Progesterone—ABCB1—ovarian cancer	5.37e-05	0.0136	CrCbGaD
Spironolactone—Testosterone—ABCB1—ovarian cancer	5.07e-05	0.0129	CrCbGaD
Spironolactone—SLCO1A2—Metabolism—CYTB—ovarian cancer	3.6e-05	0.000671	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—HRAS—ovarian cancer	3.58e-05	0.000667	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	3.57e-05	0.000666	CbGpPWpGaD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—TP53—ovarian cancer	3.54e-05	0.000661	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	3.52e-05	0.000656	CbGpPWpGaD
Spironolactone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ovarian cancer	3.5e-05	0.000653	CbGpPWpGaD
Spironolactone—SLCO1A2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	3.49e-05	0.000651	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—MYC—ovarian cancer	3.49e-05	0.000651	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	3.48e-05	0.000649	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	3.47e-05	0.000648	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—CXCL8—ovarian cancer	3.45e-05	0.000644	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—IL6—ovarian cancer	3.42e-05	0.000639	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—MAPK1—ovarian cancer	3.41e-05	0.000637	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—EGFR—ovarian cancer	3.41e-05	0.000636	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	3.4e-05	0.000634	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA1—ovarian cancer	3.39e-05	0.000633	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—YAP1—ovarian cancer	3.36e-05	0.000628	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	3.33e-05	0.000621	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—CASP3—ovarian cancer	3.3e-05	0.000616	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	3.29e-05	0.000614	CbGpPWpGaD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—IL6—ovarian cancer	3.24e-05	0.000605	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—KRAS—ovarian cancer	3.22e-05	0.000601	CbGpPWpGaD
Spironolactone—NR3C1—Adipogenesis—STAT3—ovarian cancer	3.21e-05	0.000599	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—CXCL8—ovarian cancer	3.19e-05	0.000596	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—FASN—ovarian cancer	3.18e-05	0.000594	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—ovarian cancer	3.18e-05	0.000594	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	3.18e-05	0.000593	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—AKT1—ovarian cancer	3.16e-05	0.000589	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PPP1CC—ovarian cancer	3.15e-05	0.000587	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—BRIP1—ovarian cancer	3.15e-05	0.000587	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	3.14e-05	0.000586	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—SLC5A5—ovarian cancer	3.13e-05	0.000584	CbGpPWpGaD
Spironolactone—NR3C2—Generic Transcription Pathway—MYC—ovarian cancer	3.09e-05	0.000577	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—ovarian cancer	3.07e-05	0.000572	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—AQP3—ovarian cancer	3.06e-05	0.000571	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—CASP3—ovarian cancer	3.06e-05	0.00057	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—IL2—ovarian cancer	3.05e-05	0.00057	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—PARP1—ovarian cancer	3.04e-05	0.000567	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—SLC2A1—ovarian cancer	3.02e-05	0.000564	CbGpPWpGaD
Spironolactone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—ovarian cancer	3.02e-05	0.000563	CbGpPWpGaD
Spironolactone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—ovarian cancer	3e-05	0.000559	CbGpPWpGaD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—ovarian cancer	2.99e-05	0.000558	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	2.97e-05	0.000554	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	2.97e-05	0.000554	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.96e-05	0.000552	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—ATP7B—ovarian cancer	2.93e-05	0.000547	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	2.93e-05	0.000546	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—ovarian cancer	2.92e-05	0.000544	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—CYP1B1—ovarian cancer	2.9e-05	0.000541	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	2.89e-05	0.000539	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—TP53—ovarian cancer	2.86e-05	0.000534	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—ESR1—ovarian cancer	2.86e-05	0.000534	CbGpPWpGaD
Spironolactone—AR—Gene Expression—YAP1—ovarian cancer	2.85e-05	0.000532	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	2.83e-05	0.000527	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	2.83e-05	0.000527	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—VEGFA—ovarian cancer	2.8e-05	0.000523	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—ESR1—ovarian cancer	2.76e-05	0.000515	CbGpPWpGaD
Spironolactone—SLCO1A2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	2.75e-05	0.000514	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—HDAC6—ovarian cancer	2.75e-05	0.000513	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—NME2—ovarian cancer	2.74e-05	0.000512	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—FASN—ovarian cancer	2.74e-05	0.000512	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—SLC5A5—ovarian cancer	2.7e-05	0.000503	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	2.67e-05	0.000498	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—SLC2A1—ovarian cancer	2.61e-05	0.000486	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—VEGFA—ovarian cancer	2.59e-05	0.000484	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PPP2R1A—ovarian cancer	2.57e-05	0.00048	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.56e-05	0.000477	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—IL6—ovarian cancer	2.55e-05	0.000477	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.55e-05	0.000476	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	2.51e-05	0.000468	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—CYP1B1—ovarian cancer	2.5e-05	0.000466	CbGpPWpGaD
Spironolactone—AR—Gene Expression—PGR—ovarian cancer	2.49e-05	0.000464	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—PPP2R1A—ovarian cancer	2.46e-05	0.00046	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	2.45e-05	0.000458	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—YAP1—ovarian cancer	2.43e-05	0.000454	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—AKT1—ovarian cancer	2.42e-05	0.000451	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—NME2—ovarian cancer	2.39e-05	0.000446	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—ABCB1—ovarian cancer	2.39e-05	0.000445	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—XIAP—ovarian cancer	2.38e-05	0.000445	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	2.37e-05	0.000443	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—TYMS—ovarian cancer	2.34e-05	0.000437	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	2.33e-05	0.000434	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—SMARCA4—ovarian cancer	2.32e-05	0.000433	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	2.32e-05	0.000432	CbGpPWpGaD
Spironolactone—AR—Gene Expression—PARP1—ovarian cancer	2.31e-05	0.000432	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	2.29e-05	0.000428	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—EREG—ovarian cancer	2.27e-05	0.000423	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	2.26e-05	0.000423	CbGpPWpGaD
Spironolactone—NR3C1—Adipogenesis—IL6—ovarian cancer	2.24e-05	0.000418	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PPP2R1A—ovarian cancer	2.22e-05	0.000413	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.2e-05	0.000411	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—YAP1—ovarian cancer	2.16e-05	0.000403	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	2.14e-05	0.000399	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—YAP1—ovarian cancer	2.11e-05	0.000394	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—ESR1—ovarian cancer	2.09e-05	0.000391	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	2.09e-05	0.00039	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—ABCB1—ovarian cancer	2.06e-05	0.000384	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—TYMS—ovarian cancer	2.02e-05	0.000377	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	2e-05	0.000374	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PARP1—ovarian cancer	1.97e-05	0.000368	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—IL6—ovarian cancer	1.94e-05	0.000362	CbGpPWpGaD
Spironolactone—ABCB1—HIF-1-alpha transcription factor network—AKT1—ovarian cancer	1.91e-05	0.000357	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	1.9e-05	0.000354	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—CAV1—ovarian cancer	1.89e-05	0.000353	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—PGR—ovarian cancer	1.89e-05	0.000352	CbGpPWpGaD
Spironolactone—PGR—Generic Transcription Pathway—MYC—ovarian cancer	1.88e-05	0.000352	CbGpPWpGaD
Spironolactone—AR—Gene Expression—PPP2R1A—ovarian cancer	1.88e-05	0.00035	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.84e-05	0.000342	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.8e-05	0.000337	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CYTB—ovarian cancer	1.77e-05	0.00033	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—PARP1—ovarian cancer	1.76e-05	0.000327	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—ESR1—ovarian cancer	1.74e-05	0.000325	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.73e-05	0.000322	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PIK3CG—ovarian cancer	1.72e-05	0.000321	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—FASN—ovarian cancer	1.72e-05	0.000321	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—SLC5A5—ovarian cancer	1.69e-05	0.000316	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	1.66e-05	0.00031	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—SLC2A1—ovarian cancer	1.63e-05	0.000305	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—CAV1—ovarian cancer	1.63e-05	0.000304	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PPP2R1A—ovarian cancer	1.6e-05	0.000299	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.6e-05	0.000299	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CYP1B1—ovarian cancer	1.57e-05	0.000292	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.56e-05	0.00029	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	1.55e-05	0.000289	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PPP1CC—ovarian cancer	1.55e-05	0.000288	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—BRIP1—ovarian cancer	1.55e-05	0.000288	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CYTB—ovarian cancer	1.54e-05	0.000287	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	1.54e-05	0.000287	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—MAPK3—ovarian cancer	1.53e-05	0.000286	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PIK3CD—ovarian cancer	1.51e-05	0.000282	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	1.51e-05	0.000281	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	1.49e-05	0.000279	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—MYC—ovarian cancer	1.49e-05	0.000278	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PIK3CG—ovarian cancer	1.48e-05	0.000277	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	1.47e-05	0.000274	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	1.45e-05	0.000271	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—MYC—ovarian cancer	1.44e-05	0.000268	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—PPP2R1A—ovarian cancer	1.42e-05	0.000266	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	1.42e-05	0.000264	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PPP2R1A—ovarian cancer	1.39e-05	0.000259	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.38e-05	0.000258	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PPP1CC—ovarian cancer	1.35e-05	0.000251	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—BRIP1—ovarian cancer	1.35e-05	0.000251	CbGpPWpGaD
Spironolactone—AR—Gene Expression—ESR1—ovarian cancer	1.33e-05	0.000248	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PIK3CB—ovarian cancer	1.32e-05	0.000246	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PIK3CD—ovarian cancer	1.3e-05	0.000243	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—ABCB1—ovarian cancer	1.29e-05	0.000241	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	1.28e-05	0.000239	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TERT—ovarian cancer	1.27e-05	0.000237	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—TYMS—ovarian cancer	1.27e-05	0.000236	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	1.21e-05	0.000226	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	1.18e-05	0.00022	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CAV1—ovarian cancer	1.18e-05	0.00022	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	1.15e-05	0.000215	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	1.15e-05	0.000215	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PTEN—ovarian cancer	1.14e-05	0.000213	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PIK3CB—ovarian cancer	1.14e-05	0.000212	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—ESR1—ovarian cancer	1.13e-05	0.000212	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.13e-05	0.00021	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IL6ST—ovarian cancer	1.12e-05	0.000208	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—MYC—ovarian cancer	1.09e-05	0.000203	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	1.09e-05	0.000203	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—APC—ovarian cancer	1.07e-05	0.0002	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PIK3CG—ovarian cancer	1.07e-05	0.0002	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—YAP1—ovarian cancer	1.04e-05	0.000193	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—AKT1—ovarian cancer	1.03e-05	0.000193	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.03e-05	0.000191	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CAV1—ovarian cancer	1.02e-05	0.00019	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—ESR1—ovarian cancer	1.01e-05	0.000188	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	1e-05	0.000187	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PTEN—ovarian cancer	9.82e-06	0.000183	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	9.75e-06	0.000182	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	9.67e-06	0.00018	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PIK3CD—ovarian cancer	9.42e-06	0.000176	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—MAPK3—ovarian cancer	9.33e-06	0.000174	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PIK3CG—ovarian cancer	9.3e-06	0.000173	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—MYC—ovarian cancer	9.07e-06	0.000169	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—YAP1—ovarian cancer	9.03e-06	0.000169	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	9.02e-06	0.000168	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—FASN—ovarian cancer	8.45e-06	0.000158	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—ERBB2—ovarian cancer	8.32e-06	0.000155	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—SLC5A5—ovarian cancer	8.31e-06	0.000155	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PIK3CB—ovarian cancer	8.21e-06	0.000153	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MTOR—ovarian cancer	8.21e-06	0.000153	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PIK3CD—ovarian cancer	8.17e-06	0.000153	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	8.17e-06	0.000152	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PIK3CA—ovarian cancer	8.04e-06	0.00015	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—SLC2A1—ovarian cancer	8.03e-06	0.00015	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CXCL8—ovarian cancer	7.89e-06	0.000147	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	7.86e-06	0.000147	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CDKN1B—ovarian cancer	7.71e-06	0.000144	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CYP1B1—ovarian cancer	7.7e-06	0.000144	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CASP3—ovarian cancer	7.55e-06	0.000141	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IL2—ovarian cancer	7.54e-06	0.000141	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—FASN—ovarian cancer	7.36e-06	0.000137	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CCND1—ovarian cancer	7.35e-06	0.000137	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CTNNB1—ovarian cancer	7.28e-06	0.000136	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—SLC5A5—ovarian cancer	7.24e-06	0.000135	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MMP9—ovarian cancer	7.14e-06	0.000133	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PIK3CB—ovarian cancer	7.12e-06	0.000133	CbGpPWpGaD
Spironolactone—AR—Gene Expression—MAPK3—ovarian cancer	7.11e-06	0.000133	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PTEN—ovarian cancer	7.1e-06	0.000132	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—SLC2A1—ovarian cancer	6.99e-06	0.000131	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PIK3CA—ovarian cancer	6.93e-06	0.000129	CbGpPWpGaD
Spironolactone—AR—Gene Expression—MYC—ovarian cancer	6.91e-06	0.000129	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PPP2R1A—ovarian cancer	6.83e-06	0.000127	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	6.79e-06	0.000127	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CYP1B1—ovarian cancer	6.71e-06	0.000125	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—AKT1—ovarian cancer	6.57e-06	0.000123	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—VEGFA—ovarian cancer	6.41e-06	0.00012	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—STAT3—ovarian cancer	6.35e-06	0.000118	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ABCB1—ovarian cancer	6.34e-06	0.000118	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NRAS—ovarian cancer	6.33e-06	0.000118	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—AKT1—ovarian cancer	6.29e-06	0.000117	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—TYMS—ovarian cancer	6.22e-06	0.000116	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PTEN—ovarian cancer	6.16e-06	0.000115	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MAPK3—ovarian cancer	6.06e-06	0.000113	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PPP2R1A—ovarian cancer	5.95e-06	0.000111	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MYC—ovarian cancer	5.9e-06	0.00011	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MAPK1—ovarian cancer	5.77e-06	0.000108	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—EGFR—ovarian cancer	5.77e-06	0.000108	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—AKT1—ovarian cancer	5.66e-06	0.000106	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—KRAS—ovarian cancer	5.45e-06	0.000102	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—TYMS—ovarian cancer	5.42e-06	0.000101	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—MAPK3—ovarian cancer	5.39e-06	0.000101	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—MYC—ovarian cancer	5.24e-06	9.78e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CAV1—ovarian cancer	5.02e-06	9.36e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PIK3CA—ovarian cancer	5.01e-06	9.34e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TP53—ovarian cancer	4.84e-06	9.04e-05	CbGpPWpGaD
Spironolactone—AR—Gene Expression—AKT1—ovarian cancer	4.79e-06	8.94e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.79e-06	8.94e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—HRAS—ovarian cancer	4.63e-06	8.64e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PIK3CG—ovarian cancer	4.57e-06	8.53e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IL6—ovarian cancer	4.43e-06	8.27e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CAV1—ovarian cancer	4.37e-06	8.15e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PIK3CA—ovarian cancer	4.34e-06	8.1e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—AKT1—ovarian cancer	4.09e-06	7.63e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PIK3CD—ovarian cancer	4.02e-06	7.49e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PIK3CG—ovarian cancer	3.98e-06	7.43e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—AKT1—ovarian cancer	3.64e-06	6.78e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—AKT1—ovarian cancer	3.55e-06	6.62e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PIK3CB—ovarian cancer	3.5e-06	6.53e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PIK3CD—ovarian cancer	3.5e-06	6.53e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PIK3CB—ovarian cancer	3.05e-06	5.69e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PTEN—ovarian cancer	3.03e-06	5.64e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PTEN—ovarian cancer	2.64e-06	4.92e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PIK3CA—ovarian cancer	2.13e-06	3.98e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PIK3CA—ovarian cancer	1.86e-06	3.47e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—AKT1—ovarian cancer	1.74e-06	3.25e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—AKT1—ovarian cancer	1.52e-06	2.83e-05	CbGpPWpGaD
